CODX
Co-Diagnostics, Inc. Common Stock
NASDAQ: CODX · HEALTHCARE · MEDICAL DEVICES
$1.53
-6.13% today
Updated 2026-04-29
Market cap
$5.94M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-35.25
Dividend yield
—
52W range
$1 – $47
Volume
1.5M
Co-Diagnostics, Inc. Common Stock (CODX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $10000.00 | $0.00 | $7662.00 | $39911.00 | $214974.00 | $74.55M | $97.89M | $34.22M | $6.81M | $3.92M | $622489.00 |
| Revenue growth (YoY) | — | — | -100.0% | — | +420.9% | +438.6% | +34579.9% | +31.3% | -65.0% | -80.1% | -42.5% | -84.1% |
| Cost of revenue | $0.00 | $43140.00 | $37491.00 | $302.00 | $9391.00 | $112431.00 | $16.59M | $11.57M | $5.48M | $4.18M | $999124.00 | $222377.00 |
| Gross profit | $0.00 | $10000.00 | $-37491.00 | $7360.00 | $30520.00 | $102543.00 | $57.96M | $86.31M | $28.74M | $2.63M | $2.92M | $400112.00 |
| Gross margin | — | 100.0% | — | 96.1% | 76.5% | 47.7% | 77.7% | 88.2% | 84.0% | 38.6% | 74.5% | 64.3% |
| R&D | $311476.00 | $806913.00 | $731474.00 | $1.00M | $1.36M | $1.37M | $3.19M | $14.96M | $17.44M | $22.96M | $20.98M | $19.14M |
| SG&A | $482649.00 | $846825.00 | $796896.00 | $3.10M | $3.57M | $3.50M | $8.28M | $11.55M | $14.26M | $14.28M | $16.16M | $9.06M |
| Operating income | $-1.03M | $-1.97M | $-1.69M | $-4.56M | $-6.12M | $-5.89M | $41.69M | $46.06M | $-26.98M | $-42.71M | $-40.08M | $-31.28M |
| Operating margin | — | -19679.8% | — | -59567.6% | -15328.6% | -2741.6% | 55.9% | 47.1% | -78.8% | -626.9% | -1023.7% | -5025.5% |
| EBITDA | $-1.02M | $-1.92M | $-1.65M | $-6.60M | $-6.09M | $-6.02M | $41.83M | $46.40M | $-10.31M | $-41.48M | $-38.70M | $-30.18M |
| EBITDA margin | — | -19248.4% | — | -86177.7% | -15249.0% | -2801.8% | 56.1% | 47.4% | -30.1% | -608.9% | -988.6% | -4847.7% |
| EBIT | $-1.03M | $-1.97M | $-1.69M | $-6.65M | $-6.14M | $-6.09M | $41.69M | $46.06M | $-11.59M | $-42.71M | $-40.08M | $-31.28M |
| Interest expense | $0.00 | $75189.00 | $240720.00 | $310233.00 | $134947.00 | $106437.00 | $175.00 | $473512.00 | $14.88M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.05M | $-2.04M | $-1.93M | $-6.96M | $-6.27M | $-6.20M | $42.48M | $36.66M | $-14.24M | $-35.33M | $-37.64M | $-46.90M |
| Net income growth (YoY) | — | -94.9% | +5.6% | -260.8% | +9.9% | +1.2% | +785.6% | -13.7% | -138.8% | -148.2% | -6.5% | -24.6% |
| Profit margin | — | -20431.7% | — | -90827.9% | -15714.3% | -2882.0% | 57.0% | 37.5% | -41.6% | -518.7% | -961.4% | -7533.6% |